Research News

  • Weaver & Lester-Coll Examine Impact of Health Insurance Coverage on Liver Cancer Patients
    An analysis by UVM medical student Benjamin Weaver and UVM Cancer Center member and Assistant Professor of Radiation Oncology Nataniel Lester-Coll, M.D., illustrated both health disparities and parities across a cohort of 100,000+ patients with the most common form of liver cancer. Their results were published in the Journal of Vascular and Interventional Radiology.
  • UVM’s Redox Researchers Collaborate with Scholars at Japan’s Tohoku University
    Albert van der Vliet, Ph.D., professor of pathology and laboratory medicine, participated in a six-week Invited Fellowship at Tohoku University in Sendai, Japan, engaging in research on environmental medicine and molecular toxicology. The fellowship coincided with a medley of scientific meetings and symposia that brought together leading scientists from around the world in the specific research fields of nitric oxide biology. Dr. van der Vliet, Yvonne Janssen-Heininger, Ph.D., and Brian Cunniff, Ph.D. participated as invited speakers. Additional Japanese federal funding supports the exchange of invited researchers, graduate students and post-doctoral scholars to collaborate on research.
  • Cushman and Colleagues Find Social Disparities in Treatments and Outcomes for Pulmonary Embolism
    Racial minorities and people with lower incomes or who are insured by Medicare or Medicaid are significantly less likely to receive the most advanced therapies and more likely to die after suffering a pulmonary embolism, according to a new analysis conducted by University of Vermont Professor of Medicine Mary Cushman, M.D., M.Sc., and colleagues.
  • Inaugural Juckett Scholars Launch Cancer Care Delivery Studies
    The University of Vermont Cancer Center recently announced the names of the inaugural Juckett Scholars. The award program is part of the new Clinician Investigator Development Initiative and is supported by the Juckett Foundation.
  • Innovative Approaches Hold Promise for Improving Rural Health Across Region
    Located in a rural state with a population among the oldest in the nation, the Larner College of Medicine has long been committed to finding innovative ways to provide and improve access to health care for not only the elderly, but also all residents, regardless of location or socioeconomic status. Several research initiatives at the college focus on new approaches to help patients in these regions.
  • Tracy Named Larner's Next Senior Associate Dean for Research
    J. Kathleen (Kate) Tracy, Ph.D., has been appointed as senior associate dean for research and professor of medicine at the Larner College of Medicine and director of research at the UVM Health Network. She will begin her new role in February 2023.
  • Cancer Center's Sajisevi & Colleagues Find Most Thyroid Cancers Detected in Asymptomatic Patients
    Assistant Professor of Surgery Mirabelle Sajisevi, M.D., and colleagues published a study in JAMA Otolaryngology - Head and Neck Surgery regarding geographical variation in modes of detection for thyroid cancer, a disease that has risen dramatically in incidence since the 1990s.
  • Larner Holds 2022 Excellence in Research Celebration, Presents Awards
    The University of Vermont Larner College of Medicine held the 2022 Dean's Excellence in Research three-day celebration October 31 through November 2.
  • Celebrating Larner’s Newest Facility: The Firestone Medical Research Building
    On October 27, 2022, the UVM Larner College of Medicine held a grand opening and dedication of the newest addition to the medical campus: the Firestone Medical Research Building.
  • “Convergence” Event Brings Global Cancer Treatment Experts, Local Students to Campus
    A national cancer research event called Convergence brought experts from around the country and the world to the University of Vermont October 24-27 to discuss interdisciplinary techniques to advance cancer treatment. The experts, along with UVM Cancer Center faculty, presented information about their cutting-edge cancer research.